![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
2. Aa 2414
3. Aa-2414
4. Abt-001
1. 112665-43-7
2. Bronica
3. Abbott 73001
4. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic Acid
5. Abt-001
6. Aa-2414
7. Abbott-73001
8. Aa 2414
9. (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
10. A-73001
11. 103185-78-0
12. Nsc-759640
13. 4u58jm421n
14. Ncgc00181296-01
15. Dsstox_cid_1397
16. Dsstox_rid_76138
17. Dsstox_gsid_21397
18. Seratrodast [usan:inn]
19. Abt 001
20. (+/-)-2,4,5-trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
21. Bronica (tn)
22. Ccris 8939
23. Cas-112665-43-7
24. A 73001
25. Unii-4u58jm421n
26. Seratrodast (jan/usan/inn)
27. 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
28. Seratrodast- Bio-x
29. Seratrodast [mi]
30. Seratrodast [inn]
31. Seratrodast [jan]
32. Seratrodast [usan]
33. (+-)-2,4,5-trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
34. Benzeneheptanoic Acid, Zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-
35. Seratrodast [mart.]
36. Schembl98402
37. Seratrodast [who-dd]
38. Mls006012011
39. Dtxsid4021397
40. Chebi:32126
41. Seratrodast, >=98% (hplc)
42. Hms3264k16
43. Hms3748i13
44. Pharmakon1600-01502336
45. Act02647
46. Bcp08860
47. Hy-b0774
48. Tox21_112774
49. Mfcd00875701
50. Nsc759640
51. S2072
52. Stl556121
53. (+/-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
54. Akos015911825
55. Seratrodast(aa-2414, Abt-001)
56. Tox21_112774_1
57. Ccg-207903
58. Db06739
59. Nsc 759640
60. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1-cyclohexa-1,4-dienyl)heptanoic Acid
61. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)heptanoic Acid
62. Ncgc00181296-02
63. As-12945
64. Bs164397
65. Smr002530529
66. Ft-0631064
67. D01123
68. Ab01563274_01
69. 665s437
70. A802627
71. L001973
72. Sr-01000944172
73. J-002813
74. Q7452735
75. Sr-01000944172-1
76. 6-(6-carboxy-1-phenylhexyl)-2,3,5-trimethylbenzoquinone
77. 7-(3,5,6-trimethyl-1,4-benzoquinone-2-yl)-7-phenylheptanoic Acid
78. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadienyl)heptanoic Acid
79. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)heptanoic Acid
80. (+/-)-2,4,5-trimethyl-3,6-dioxo-.zeta.-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
81. 7-phenyl-7-[2,4,5-trimethyl-3,6-bis(oxidanylidene)cyclohexa-1,4-dien-1-yl]heptanoic Acid
82. Benzeneoctanoic Acid,h-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-
83. 103186-19-2
84. Benzeneheptanoic Acid, .zeta.-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+/-)-
Molecular Weight | 354.4 g/mol |
---|---|
Molecular Formula | C22H26O4 |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 354.18310931 g/mol |
Monoisotopic Mass | 354.18310931 g/mol |
Topological Polar Surface Area | 71.4 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 633 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Asthmatic Agents
Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Prostaglandin Antagonists
Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03D - Other systemic drugs for obstructive airway diseases
R03DX - Other systemic drugs for obstructive airway diseases
R03DX06 - Seratrodast
Seratrodast has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoyl]oxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560